Health Care Innovation
California
Single Payer Is Fool’s Gold For California
While the latest Republican attempt to repeal and replace ObamaCare may have failed, Democrats in California and in D.C. are just getting started in their effort to eliminate the health law. Unfortunately, they’re angling to replace ObamaCare with something even worse. In California, State Senators Ricardo Lara and Toni Atkins ...
Sally C. Pipes
March 31, 2017
California
California Single-Payer Bill Looks Backward, Instead Of Forward To A New Era Of Patient Choice
Here we go again. The California State Legislature is considering yet another bill to impose a so-called single-payer, government monopoly, health care system. This has long been an obsession of the California’s nurses unions, because a health system under total government control would suit the narrow interests of union leaders. ...
John R. Graham
March 23, 2017
Commentary
Oregon’s Drug Price Bill Is Hard To Swallow
President Donald Trump is not the only politician saying he is going to work to get drug prices down. Oregon lawmakers are already patting themselves on the back for tackling drug prices. Rep. Mitch Greenlick (D-Portland) says the measure, Oregon House Bill 2387, could be a model for national reform. ...
Sally C. Pipes
March 2, 2017
Drug Innovation
ISSUE BRIEF: Oregon Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Pacific Research Institute
March 1, 2017
Drug Innovation
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Pacific Research Institute
March 1, 2017
Commentary
Drug Importation Won’t Save Dollars Or Lives
A recent oped in The Hill by MedShadow Foundation founder Suzanne Robotti claims that permitting Americans to import prescription drugs from Canada would save dollars and lives. It would do neither. Prescription drug importation has several notable proponents, like Sens. John McCain (R-Ariz.), Amy Kobuchar (D-Minn.), and Bernie Sanders (I-Vt.), ...
Sally C. Pipes
February 24, 2017
Drug Pricing
Health Care Expert: If Obamacare Isn’t Immediately Repealed, Then It Likely Never Will Be
Ever since the Affordable Care Act — colloquially known as “Obamacare” — was signed into law in March 2010, the primary goal of congressional Republicans has been to repeal the law and replace it with a market-based solution that they say works for all Americans. For years, Republicans were only ...
Chris Enloe
January 19, 2017
Commentary
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
Sally C. Pipes
January 10, 2017
Business & Economics
Drug Importation Is Not The Answer
The imminent repeal of the Affordable Care Act (aka Obamacare) is garnering most of the health care headlines, and rightly so. But, the focus on Obamacare should not overshadow other health care modifications that may be considered during the 115th Congress. Paramount among these proposals is the issue of drug ...
Wayne Winegarden
January 5, 2017
Health Care
Post-Election Top Policy Changes To Watch In 2017
While every new year brings change, with Donald Trump elected to become the next president and the U.S. House and Senate both having Republican majorities, managed healthcare executives will see more changes than usual in 2017—beginning with repealing and replacing most of the provisions in the Affordable Care Act (ACA). ...
Karen Appold
January 2, 2017
Single Payer Is Fool’s Gold For California
While the latest Republican attempt to repeal and replace ObamaCare may have failed, Democrats in California and in D.C. are just getting started in their effort to eliminate the health law. Unfortunately, they’re angling to replace ObamaCare with something even worse. In California, State Senators Ricardo Lara and Toni Atkins ...
California Single-Payer Bill Looks Backward, Instead Of Forward To A New Era Of Patient Choice
Here we go again. The California State Legislature is considering yet another bill to impose a so-called single-payer, government monopoly, health care system. This has long been an obsession of the California’s nurses unions, because a health system under total government control would suit the narrow interests of union leaders. ...
Oregon’s Drug Price Bill Is Hard To Swallow
President Donald Trump is not the only politician saying he is going to work to get drug prices down. Oregon lawmakers are already patting themselves on the back for tackling drug prices. Rep. Mitch Greenlick (D-Portland) says the measure, Oregon House Bill 2387, could be a model for national reform. ...
ISSUE BRIEF: Oregon Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Issue Brief: Proposal To Regulate Excess Costs Is Price Controls By Another Name
Introduced in February, HB 2387 would require pharmaceutical firms to reimburse insurers for any “excess costs” associated with covered drugs. Excess costs are defined as the difference between the average wholesale price of a drug and either: the typical price in other countries; or, the difference between a health plan’s ...
Drug Importation Won’t Save Dollars Or Lives
A recent oped in The Hill by MedShadow Foundation founder Suzanne Robotti claims that permitting Americans to import prescription drugs from Canada would save dollars and lives. It would do neither. Prescription drug importation has several notable proponents, like Sens. John McCain (R-Ariz.), Amy Kobuchar (D-Minn.), and Bernie Sanders (I-Vt.), ...
Health Care Expert: If Obamacare Isn’t Immediately Repealed, Then It Likely Never Will Be
Ever since the Affordable Care Act — colloquially known as “Obamacare” — was signed into law in March 2010, the primary goal of congressional Republicans has been to repeal the law and replace it with a market-based solution that they say works for all Americans. For years, Republicans were only ...
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
Drug Importation Is Not The Answer
The imminent repeal of the Affordable Care Act (aka Obamacare) is garnering most of the health care headlines, and rightly so. But, the focus on Obamacare should not overshadow other health care modifications that may be considered during the 115th Congress. Paramount among these proposals is the issue of drug ...
Post-Election Top Policy Changes To Watch In 2017
While every new year brings change, with Donald Trump elected to become the next president and the U.S. House and Senate both having Republican majorities, managed healthcare executives will see more changes than usual in 2017—beginning with repealing and replacing most of the provisions in the Affordable Care Act (ACA). ...